Mativ Holdings, Inc.MATVNYSE
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P21
Within normal range
vs 3Y Ago
-0.3x
Contraction
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q4 2025-10.71%
Q3 2025-16.42%
Q2 20256.35%
Q1 202514.55%
Q4 2024-3.51%
Q3 2024-1.72%
Q2 2024-3.33%
Q1 202430.43%
Q4 2023-14.81%
Q3 202320.00%
Q2 2023-32.84%
Q1 2023-19.28%
Q4 202240.68%
Q3 20229.26%
Q2 20223.85%
Q1 2022-3.70%
Q4 2021-5.26%
Q3 20215.56%
Q2 202142.11%
Q1 202111.76%
Q4 2020-5.56%
Q3 20200.00%
Q2 202012.50%
Q1 2020-5.88%
Q4 20199.68%
Q3 2019-16.22%
Q2 201912.12%
Q1 2019-2.94%
Q4 2018-5.56%
Q3 2018-12.20%
Q2 20180.00%
Q1 2018-16.33%
Q4 201725.64%
Q3 2017-15.22%
Q2 20174.55%
Q1 2017-4.35%
Q4 20169.52%
Q3 2016-4.55%
Q2 20162.33%
Q1 201622.86%